Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Methylprednisolone in Preventing Adverse Cerebrovascular Events After Flow-Diverter Stent Implantation in Patients With Unruptured Intracranial Aneurysms: A Multicenter, Prospective, Randomized, Double-Blind, Placebo-Controlled Clinical Trial

NCT07353749 is registered in ClinicalTrials.gov with Duan Chuanzhi as lead sponsor.

NCT NCT07353749
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07353749 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Methylprednisolone in Preventing Adverse Cerebrovascular Events After Flow-Diverter Stent Implantation in Patients With Unruptured Intracranial Aneurysms: A Multicenter, Prospective, Randomized, Double-Blind, Placebo-Controlled Clinical Trial
Lead sponsor
Duan Chuanzhi
Phase
Phase 4
Overall status
Not yet recruiting
Start date
January 30, 2026
Completion date
September 1, 2027
Enrollment
864 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cerebrovascular event, flow diverter, hemorrhagic stroke, methylprednisolone, unruptured intracranial aneurysms